Herein, we identified seven robust prognostic markers (SIGLEC14, GHRHR, TAS2R1, CDKL1, ZSCAN10, TBX15, and CD101) that were independent factors significantly correlated with the TTR of the primary GBM samples (Fig. 6A). The gene discussed is ZSCAN10; the disease is glioblastoma.